MAGEE2

Model summary

A soluble regulatory scaffold that uses a bipartite MAGE homology domain with tandem winged-helix modules to assemble transcriptional repression complexes. By forming multivalent protein–protein interfaces, it recruits chromatin-modifying and corepressor assemblies to attenuate RNA polymerase II–driven gene expression and dampen Notch pathway outputs. Its soluble architecture supports shuttling between cytosol and nucleoplasm, where it modulates transcriptional programs central to cell-state control.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The polypeptide is dominated by a bipartite MAGE homology domain (MHD) that appears in two large cores: an N-terminal core spanning residues 88–288 (IPR002190: MAGE homology domain) and a C-terminal core spanning residues 311–502 (IPR002190: MAGE homology domain). These two cores are each subdivided into winged-helix modules: WH1 motif in the N-terminal core (IPR041898, residues 68–165) and WH2 motif in the N-terminal core (IPR041899, residues 166–297), followed by a second WH1 motif (IPR041898, residues 306–385) and WH2 motif (IPR041899, residues 387–511) that complete the C-terminal core. The family-level signature IPR037445 (Melanoma-associated antigen family, residues 26–295) reinforces that this is a canonical MAGE-type scaffold. The ordered arrangement—tandem winged-helix repeats embedded within two contiguous MHD cores—creates an extended, non-enzymatic binding platform. Winged-helix folds typically mediate nucleic acid and protein interactions; in MAGE proteins, this architecture causes high-affinity, multivalent protein binding rather than catalysis, aligning with GO:0005515 protein binding as the primary molecular function.

2. 02

   From this binding-centric scaffold, I infer regulatory roles.

   MAGE cores frequently assemble transcriptional repression modules by docking chromatin regulators and sequence-specific transcription factors. The presence of multiple winged-helix motifs supports avid assembly of repression complexes that attenuate RNA polymerase II-driven transcription, consistent with GO:0000122 negative regulation of transcription by RNA polymerase II. The same scaffold can tune developmental signaling circuits; by recruiting corepressors and histone-modifying enzymes to Notch-responsive loci, it can dampen pathway output, matching GO:0045746 negative regulation of Notch signaling pathway. Thus, the domain architecture directly drives transcriptional repression and pathway attenuation through modular complex formation.

3. 03

   Cellular localization follows from function and fold.

   The absence of transmembrane segments and the reliance on protein–protein interaction modules indicate a soluble intracellular protein. Repression of RNA polymerase II targets and modulation of Notch signaling both require access to chromatin and transcriptional machinery, placing the protein in the nucleoplasm (GO:0005654 nucleoplasm). Many transcriptional regulators shuttle and assemble in the cytosol before nuclear entry; the soluble architecture and broad binding capacity support cytosolic residence as well (GO:0005829 cytosol). This dual soluble distribution coherently explains the experimentally observed cytoplasmic and nuclear presence.

4. 04

   Mechanistically, I hypothesize that the MHD platform nucleates a repression hub: the N- and C-terminal cores cooperatively bind histone deacetylases and corepressors, while the winged-helix surfaces engage transcription factors and pathway-specific mediators.

   In Notch contexts, association with CSL/RBPJ-bound chromatin would reduce target gene transcription. I therefore predict interactions with nuclear corepressor assemblies (e.g., SIN3–HDAC and NuRD modules), sequence-specific transcription factors that route signaling outputs, and cytosolic adaptors that chaperone nuclear shuttling. This multivalent assembly explains how a non-enzymatic MAGE scaffold can repress transcription and dampen Notch signaling from soluble pools in the cytosol and nucleoplasm.